BACKGROUND: Whether chronic kidney disease (CKD) recognition in an electronic health record (EHR) problem list improves processes of care or clinical outcomes of end-stage renal disease (ESRD) and death is unclear. METHODS: We identified patients who had at least 1 year of follow-up (2005-2009) in our EHR-based CKD registry (n = 25,742). CKD recognition was defined by having ICD-9 codes for CKD, diabetic kidney disease, or hypertensive kidney disease in the problem list. We calculated proportions of patients with and without CKD recognition and examined differences by demographics, clinical factors, and development of ESRD or mortality. We evaluated differences in the proportion of patients with CKD-specific laboratory results checked before and after recognition among cases and propensity-matched controls. RESULTS: Only 11% (n = 2,735) had CKD recognition in the problem list and they were younger (68 vs. 71 years), a higher proportion were male (61 vs. 37%) and African-American (21 vs. 10%) compared to those unrecognized. CKD-specific laboratory results for patients with estimated glomerular filtration rate (eGFR) 30-59 including intact parathyroid hormone (23 vs. 6%), vitamin D (22 vs. 18%), phosphorus (29 vs. 7%), and a urine check for proteinuria (55 vs. 36%) were significantly more likely to be done among those with CKD recognition (all p < 0.05). Similar results were found for eGFR <30 except for proteinuria and in our propensity score-matched control analysis. There was no independent association of CKD recognition with ESRD or mortality. CONCLUSIONS: CKD recognition in the EHR problem list was low, but translated into more CKD-specific processes of care; however ESRD or mortality were not affected.
BACKGROUND: Whether chronic kidney disease (CKD) recognition in an electronic health record (EHR) problem list improves processes of care or clinical outcomes of end-stage renal disease (ESRD) and death is unclear. METHODS: We identified patients who had at least 1 year of follow-up (2005-2009) in our EHR-based CKD registry (n = 25,742). CKD recognition was defined by having ICD-9 codes for CKD, diabetic kidney disease, or hypertensive kidney disease in the problem list. We calculated proportions of patients with and without CKD recognition and examined differences by demographics, clinical factors, and development of ESRD or mortality. We evaluated differences in the proportion of patients with CKD-specific laboratory results checked before and after recognition among cases and propensity-matched controls. RESULTS: Only 11% (n = 2,735) had CKD recognition in the problem list and they were younger (68 vs. 71 years), a higher proportion were male (61 vs. 37%) and African-American (21 vs. 10%) compared to those unrecognized. CKD-specific laboratory results for patients with estimated glomerular filtration rate (eGFR) 30-59 including intact parathyroid hormone (23 vs. 6%), vitamin D (22 vs. 18%), phosphorus (29 vs. 7%), and a urine check for proteinuria (55 vs. 36%) were significantly more likely to be done among those with CKD recognition (all p < 0.05). Similar results were found for eGFR <30 except for proteinuria and in our propensity score-matched control analysis. There was no independent association of CKD recognition with ESRD or mortality. CONCLUSIONS: CKD recognition in the EHR problem list was low, but translated into more CKD-specific processes of care; however ESRD or mortality were not affected.
Authors: Basit Chaudhry; Jerome Wang; Shinyi Wu; Margaret Maglione; Walter Mojica; Elizabeth Roth; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2006-04-11 Impact factor: 25.391
Authors: David Dorr; Laura M Bonner; Amy N Cohen; Rebecca S Shoai; Ruth Perrin; Edmund Chaney; Alexander S Young Journal: J Am Med Inform Assoc Date: 2007-01-09 Impact factor: 4.497
Authors: Paul C Tang; Mary Ralston; Michelle Fernandez Arrigotti; Lubna Qureshi; Justin Graham Journal: J Am Med Inform Assoc Date: 2006-10-26 Impact factor: 4.497
Authors: Daniel M Hartung; Jacquelyn Hunt; Joseph Siemienczuk; Heather Miller; Daniel R Touchette Journal: J Gen Intern Med Date: 2005-02 Impact factor: 5.128
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Maya K Rao; Cynthia D Morris; Jean P O'Malley; Melinda M Davis; Motomi Mori; Sharon Anderson Journal: Clin J Am Soc Nephrol Date: 2013-01-31 Impact factor: 8.237
Authors: A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan Journal: Kidney Int Date: 2007-06-13 Impact factor: 10.612
Authors: J A Green; P L Ephraim; F F Hill-Briggs; T Browne; T S Strigo; C L Hauer; R A Stametz; J D Darer; U D Patel; K Lang-Lindsey; B L Bankes; S A Bolden; P Danielson; S Ruff; L Schmidt; A Swoboda; P Woods; B Vinson; D Littlewood; G Jackson; J F Pendergast; J St Clair Russell; K Collins; E Norfolk; I D Bucaloiu; S Kethireddy; C Collins; D Davis; J dePrisco; D Malloy; C J Diamantidis; S Fulmer; J Martin; D Schatell; N Tangri; A Sees; C Siegrist; J Breed; A Medley; E Graboski; J Billet; M Hackenberg; D Singer; S Stewart; A Alkon; N A Bhavsar; L Lewis-Boyer; C Martz; C Yule; R C Greer; M Saunders; B Cameron; L E Boulware Journal: Contemp Clin Trials Date: 2018-09-12 Impact factor: 2.226
Authors: Felipe S Naranjo; Yingying Sang; Shoshana H Ballew; Nikita Stempniewicz; Stephan C Dunning; Andrew S Levey; Josef Coresh; Morgan E Grams Journal: Kidney360 Date: 2021-01-06
Authors: Elaine C Khoong; Leah Karliner; Lowell Lo; Marilyn Stebbins; Andrew Robinson; Sarita Pathak; Jasmine Santoyo-Olsson; Rebecca Scherzer; Carmen A Peralta Journal: JMIR Res Protoc Date: 2019-06-07
Authors: John Heintzman; Jorge Kaufmann; Jennifer Lucas; Shakira Suglia; Arvin Garg; Jon Puro; Sophia Giebultowicz; David Ezekiel-Herrera; Andrew Bazemore; Miguel Marino Journal: J Am Board Fam Med Date: 2020 Sep-Oct Impact factor: 2.657
Authors: Hilda O Hounkpatin; Simon D S Fraser; Rory Honney; Gavin Dreyer; Alison Brettle; Paul J Roderick Journal: BMC Nephrol Date: 2020-06-09 Impact factor: 2.388